Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: DEXORGEN INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-23 to 2023-03-22
Current total value of award: $998800
Description: EO14042 DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER SBIR PHASE II